HOMI

Homi is a longevity-focused biotechnology company dedicated to extending human healthspan through the science of epigenetic reprogramming. Co-founded by renowned longevity researcher Dr. David Sinclair and entrepreneur Samer Hamadeh, the company develops advanced biological age testing kits that utilize epigenetic clocks to measure cellular aging. Beyond diagnostics, Homi is actively researching therapeutic interventions aimed at reversing the biological clock and treating age-related decline. The company's platform leverages proprietary algorithms to analyze DNA methylation patterns, providing users with personalized insights into their aging process. Homi aims to bridge the gap between cutting-edge longevity research and consumer health by making biological age management accessible and actionable.